Related Experiment Video
Updated: Jan 24, 2026

Saturated Fatty Acids Induce Ceramide-associated Macrophage Cell Death
Published on: October 31, 2017
CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation
Harri M Itkonen1, Ninu Poulose2, Suzanne Walker3
1Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forskningsparken, University of Oslo, Oslo, 0349, Norway; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, 02115, USA.
Abstract:
Cyclin-dependent kinase 9 (CDK9), a key regulator of RNA-polymerase II, is a candidate drug target for cancers driven by transcriptional deregulation. Here we report a multi-omics-profiling of prostate cancer cell responses to CDK9 inhibition to identify synthetic lethal interactions. These interactions were validated using live-cell imaging, mitochondrial flux-, viability- and cell death activation assays. We show that CDK9 inhibition induces acute metabolic stress in prostate cancer cells. This is manifested by a drastic down-regulation of mitochondrial oxidative phosphorylation, ATP depletion and induction of a rapid and sustained phosphorylation of AMP-activated protein kinase (AMPK), the key sensor of cellular energy homeostasis. We used metabolomics to demonstrate that inhibition of CDK9 leads to accumulation of acyl-carnitines, metabolic intermediates in fatty acid oxidation (FAO). Acyl-carnitines are produced by carnitine palmitoyltransferase enzymes 1 and 2 (CPT), and we used both genetic and pharmacological tools to show that inhibition of CPT-activity is synthetically lethal with CDK9 inhibition. To our knowledge this is the first report to show that CDK9 inhibition dramatically alters cancer cell metabolism.
Insights
Inhibiting cyclin-dependent kinase 9 (CDK9) causes metabolic stress in prostate cancer cells. Blocking carnitine palmitoyltransferase (CPT) activity together with CDK9 inhibition is synthetically lethal, offering a potential cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Metabolic Research
Background:
- Cyclin-dependent kinase 9 (CDK9) regulates RNA-polymerase II and is a drug target for cancers with transcriptional deregulation.
- Prostate cancer is driven by complex molecular pathways, necessitating novel therapeutic strategies.
Purpose of the Study:
- To identify synthetic lethal interactions by profiling prostate cancer cell responses to CDK9 inhibition.
- To investigate the metabolic consequences of CDK9 inhibition in prostate cancer cells.
Main Methods:
- Multi-omics profiling of prostate cancer cells.
- Live-cell imaging, mitochondrial flux, viability, and cell death assays.
- Metabolomics, genetic, and pharmacological inhibition of carnitine palmitoyltransferase (CPT).
Main Results:
- CDK9 inhibition induces acute metabolic stress, down-regulating mitochondrial oxidative phosphorylation and depleting ATP.
- AMP-activated protein kinase (AMPK) phosphorylation is rapidly induced, signaling energy depletion.
- Inhibition of CDK9 leads to acyl-carnitine accumulation, indicating altered fatty acid oxidation (FAO).
- CPT inhibition is synthetically lethal with CDK9 inhibition in prostate cancer cells.
Conclusions:
- CDK9 inhibition profoundly alters cancer cell metabolism, inducing significant metabolic stress.
- Targeting carnitine palmitoyltransferase (CPT) in combination with CDK9 inhibition presents a novel synthetic lethal strategy for prostate cancer treatment.
More Related Videos
12:11Determination of Fatty Acid Oxidation and Lipogenesis in Mouse Primary Hepatocytes
Published on: August 27, 2015
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Feedback Inhibition
Alkynes to Carboxylic Acids: Oxidative Cleavage
Oxidations of Aldehydes and Ketones to Carboxylic Acids
Aldehydes readily undergo oxidation in strong oxidizing agents such as potassium permanganate and chromic acid. The oxidation can also be carried out using mild oxidizing agents such as silver oxide. In fact, aldehydes can be easily oxidized...
What is Metabolism?
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...